CGM
SEM

Capital Growth Management’s Select Medical SEM Stock Holding History

Capital Growth Management’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,883,840
Closed -$36.7M – 80
2021
Q3 		$36.7M Buy
1,883,840
+296,960
+19% +$5.89M 3.37% 3
2021
Q2 		$36.1M Buy
+1,586,880
New +$32.9M 3.26% 5

Other funds holding SEM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Capital Growth Management's SEM Position: Q4 2021 in Review

Capital Growth Management sold out of Select Medical (SEM) in Q4 2021, closing a stake of 1,883,840 shares — an estimated $36.7M sold.

Capital Growth Management first reported a position in SEM in Q2 2021 and held it in 2 quarters. The position peaked at $36.7M in Q3 2021. 244 funds tracked by Wall St. Rank hold SEM as of Q4 2021.

  • Capital Growth Management reported no remaining Select Medical position as of Q4 2021 after selling out during the quarter.
  • Capital Growth Management sold 1,883,840 Select Medical shares in Q4 2021, an estimated $36.7M.
  • Capital Growth Management first reported a position in Select Medical in Q2 2021 and held it in 2 quarters.
  • Capital Growth Management's Select Medical position peaked at $36.7M in Q3 2021.
  • 244 funds tracked by Wall St. Rank held Select Medical as of Q4 2021.

Based on Capital Growth Management's 13F filing for Q4 2021, filed 11 Feb 2022.